Impact of hepatic steatosis on treatment response in nuclesos(t)ide analogue-treated HBeAg-positive chronic hepatitis B: a retrospective study

BACKGROUND: The impact of hepatic steatosis (HS) on treatment response following nucleos(t)ide analogue (NA) treatment for chronic hepatitis B (CHB) patients has not been clearly elucidated. We aimed to investigate the difference in HBeAg seroclearance between NA-treated HBeAg-positive CHB patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yi-Cheng, Jeng, Wen-Juei, Hsu, Chao-Wei, Lin, Chun-Yen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216492/
https://www.ncbi.nlm.nih.gov/pubmed/32397963
http://dx.doi.org/10.1186/s12876-020-01289-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216492/
https://www.ncbi.nlm.nih.gov/pubmed/32397963
http://dx.doi.org/10.1186/s12876-020-01289-w

Ejemplares similares